Yacktman Asset Management’s AbbVie ABBV Stock Holding History

Yacktman Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2,800	Closed	-$258K	–	45
2018 Q4	$258K	Hold	2,800	–	–	﹤0.01%	42
2018 Q3	$265K	Hold	2,800	–	–	﹤0.01%	40
2018 Q2	$259K	Hold	2,800	–	–	﹤0.01%	38
2018 Q1	$265K	Hold	2,800	–	–	﹤0.01%	44
2017 Q4	$271K	Hold	2,800	–	–	﹤0.01%	43
2017 Q3	$249K	Hold	2,800	–	–	﹤0.01%	45
2017 Q2	$203K	Buy	+2,800	New	+$188K	﹤0.01%	44

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Yacktman Asset Management's ABBV Position: Q1 2019 in Review

Yacktman Asset Management sold out of AbbVie (ABBV) in Q1 2019, closing a stake of 2,800 shares — an estimated $258K sold.

Yacktman Asset Management first reported a position in ABBV in Q2 2017 and held it in 7 quarters. The position peaked at $271K in Q4 2017. 2,034 funds tracked by Wall St. Rank hold ABBV as of Q1 2019.

Yacktman Asset Management reported no remaining AbbVie position as of Q1 2019 after selling out during the quarter.
Yacktman Asset Management sold 2,800 AbbVie shares in Q1 2019, an estimated $258K.
Yacktman Asset Management first reported a position in AbbVie in Q2 2017 and held it in 7 quarters.
Yacktman Asset Management's AbbVie position peaked at $271K in Q4 2017.
2,034 funds tracked by Wall St. Rank held AbbVie as of Q1 2019.

Based on Yacktman Asset Management's 13F filing for Q1 2019, filed 2 May 2019.